Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. HOLX has a PE ratio of 87. Currently there are 8 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 7 rate it a hold.

The average volume for Hologic has been 1.6 million shares per day over the past 30 days. Hologic has a market cap of $10.1 billion and is part of the health care sector and health services industry. The stock has a beta of 1.13 and a short float of 4.9% with 5.90 days to cover. Shares are up 35.1% year-to-date as of the close of trading on Monday.